Elizabeth Forminard - Johnson Johnson Exec Counsel
| JNJ Stock | 148.36 0.88 0.60% |
Insider
Elizabeth Forminard is Exec Counsel of Johnson Johnson
| Phone | 732 524 0400 |
| Web | https://www.jnj.com |
Johnson Johnson Management Efficiency
The company has return on total asset (ROA) of 0.0871 % which means that it generated a profit of $0.0871 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2379 %, meaning that it generated $0.2379 on every $100 dollars invested by stockholders. Johnson Johnson's management efficiency ratios could be used to measure how well Johnson Johnson manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Oliver Maier | Bayer AG NA | N/A | |
| Mikael MD | Pfizer Inc | 65 | |
| John Young | Pfizer Inc | 58 | |
| DVM DVM | Pfizer Inc | 60 | |
| Heiko Schipper | Bayer AG NA | 54 | |
| Gabriel Harnier | Bayer AG NA | 52 | |
| Angela Hwang | Pfizer Inc | 57 | |
| Jennifer Damico | Pfizer Inc | 55 | |
| BerndPeter Bier | Bayer AG NA | 56 | |
| Wolfgang Nickl | Bayer AG NA | 54 | |
| Michael Preuss | Bayer AG NA | N/A | |
| Frank DAmelio | Pfizer Inc | 65 | |
| Rodrigo Santos | Bayer AG NA | 50 | |
| Christopher CFA | Pfizer Inc | N/A | |
| Douglas Lankler | Pfizer Inc | 57 | |
| Lidia Fonseca | Pfizer Inc | 54 | |
| Sarena Lin | Bayer AG NA | 52 | |
| Werner Baumann | Bayer AG NA | 61 | |
| David Denton | Pfizer Inc | 58 | |
| Stefan Oelrich | Bayer AG NA | 55 | |
Management Performance
| Return On Equity | 0.24 | |||
| Return On Asset | 0.0871 |
Johnson Johnson Leadership Team
Elected by the shareholders, the Johnson Johnson's board of directors comprises two types of representatives: Johnson Johnson inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Johnson. The board's role is to monitor Johnson Johnson's management team and ensure that shareholders' interests are well served. Johnson Johnson's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Johnson Johnson's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Dirk Brinckman, Chief Officer | ||
| Robert Decker, Controller Officer | ||
| Alex Gorsky, Ex Chairman | ||
| Jessica Moore, VP Relations | ||
| Joaquin Duato, CEO Director | ||
| Joseph CPA, Ex CFO | ||
| James Swanson, Ex Officer | ||
| Elizabeth Forminard, Exec Counsel | ||
| Jennifer Taubert, Ex Pharmaceuticals | ||
| Peter Fasolo, Ex Officer |
Johnson Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Johnson Johnson a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.24 | |||
| Return On Asset | 0.0871 | |||
| Profit Margin | 0.19 % | |||
| Operating Margin | 0.27 % | |||
| Current Valuation | 443.95 B | |||
| Shares Outstanding | 2.6 B | |||
| Shares Owned By Insiders | 0.09 % | |||
| Shares Owned By Institutions | 71.68 % | |||
| Price To Book | 6.27 X | |||
| Price To Sales | 4.50 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Johnson Stock Analysis
When running Johnson Johnson's price analysis, check to measure Johnson Johnson's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Johnson Johnson is operating at the current time. Most of Johnson Johnson's value examination focuses on studying past and present price action to predict the probability of Johnson Johnson's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Johnson Johnson's price. Additionally, you may evaluate how the addition of Johnson Johnson to your portfolios can decrease your overall portfolio volatility.